Cantor Fitzgerald Reinstates TherapeuticsMD (TXMD) at Neutral Jan 10, 2023 01:03PM
Cantor Fitzgerald Reiterates Neutral Rating, $1 Price Target on TherapeuticsMD (TXMD) on Failed Acquisition Jul 13, 2022 07:44AM
Cantor Fitzgerald Reiterates Neutral Rating on TherapeuticsMD (TXMD) May 17, 2022 06:48AM
Cantor Fitzgerald Reiterates TherapeuticsMD (TXMD) at Overweight, "TXMD's Opportunity to Become Leading Women's Healthcare Company Remains Underappreciated" Mar 10, 2022 11:05AM
Cantor Fitzgerald Reiterates TherapeuticsMD (TXMD) at Overweight, $5 PT, VitaCare Sale is Good News, Priced Above Expectation, Increases Confidence in the Stock Mar 7, 2022 07:59AM


Feb 16, 2021 04:01PM TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock
Feb 11, 2021 09:03AM TherapeuticsMD (TXMD) Prices $110M Share Common Offering
Feb 11, 2021 09:02AM TherapeuticsMD Announces Pricing of $110 Million Public Offering of Common Stock
Feb 10, 2021 04:02PM TherapeuticsMD (TXMD) Announces Underwritten Public Offering of its Common Stock
Feb 10, 2021 04:01PM TherapeuticsMD Announces Underwritten Public Offering of its Common Stock
Nov 13, 2020 04:05PM TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock
Nov 10, 2020 08:59AM TherapeuticsMD (TXMD) Prices $30 Million Public Offering of Common Stock
Nov 10, 2020 08:58AM TherapeuticsMD Announces Pricing of $30 Million Public Offering of Common Stock
Nov 9, 2020 04:03PM TherapeuticsMD (TXMD) Announces Underwritten Public Offering of its Common Stock
Nov 9, 2020 04:01PM TherapeuticsMD Announces Underwritten Public Offering of its Common Stock
Sep 25, 2019 01:18PM TherapeuticsMD (TXMD) Slides Show Annovera Soft Launch Expected Next Week - Cantor Fitzgerald
Aug 15, 2019 07:17AM TherapeuticsMD (TXMD) Should Benefit From NuvaRing Delay - Cantor Fitzgerald
Jun 12, 2019 11:17AM TherapeuticsMD (TXMD) PT Lowered to $13 at Cantor Fitzgerald
Aug 6, 2018 04:05PM TherapeuticsMD Announces Closing of its Underwritten Public Offering and Concurrent Registered Direct Offering of Common Stock
Aug 2, 2018 05:56AM TherapeuticsMD (TXMD) Prices Combined $65M Common Share Offering and $20M Registered Direct Offering by Investor at $5.10/Sh
Aug 1, 2018 09:36PM TherapeuticsMD Announces Pricing of Its Underwritten Public Offering and Concurrent Registered Direct Offering for Aggregate Gross Proceeds of $85 Million
Jul 31, 2018 04:12PM TherapeuticsMD (TXMD) Announces $65M Underwritten Public Offering and Concurrent $20M Registered Direct Offering
Jul 31, 2018 04:09PM TherapeuticsMD Announces Proposed $65 Million Underwritten Public Offering and Concurrent $20 Million Registered Direct Offering of Common Stock
May 4, 2018 12:59AM TherapeuticsMD (TXMD) PT Lowered to $26 at Cantor Fitzgerald
Dec 20, 2017 06:37AM TherapeuticsMD (TXMD) PT Lowered to $28 at Cantor Fitzgerald
Sep 25, 2017 04:52PM TherapeuticsMD (TXMD) Launches 12.4M Common Stock Offering
Sep 25, 2017 04:52PM TherapeuticsMD Announces Public Offering of 12.4 Million Shares of Common Stock
Sep 7, 2017 01:23PM TherapeuticsMD (TXMD) Gains as Analysts Cover Call from WHI-OS Co-Author
Sep 6, 2017 06:55AM TherapeuticsMD to Present at Two Upcoming Investor Conferences
Apr 11, 2017 06:38AM TherapeuticsMD (TXMD): FDA Letter Implies PDUFA Date May Slide - Cantor
Apr 4, 2017 07:33AM Cantor Fitzgerald Reiterates Overweight Rating and $34 PT on TherapeuticsMD (TXMD); 'Compelling TX-001 Data' Continues
Mar 6, 2017 07:23AM TherapeuticsMD (TXMD): Investor Day Recap - Cantor
Dec 16, 2016 09:31AM Pre-Open Stock Movers 12/16: (JBL) (HZNP) (TXMD) Higher; (AGIO) (VCEL) (FNSR) Lower (more...)
Dec 16, 2016 07:56AM Cantor Fitzgerald Starts TherapeuticsMD (TXMD) at Overweight
Jan 24, 2014 09:36AM Pre-Open Stock Movers 1/24: (BDSI) (OTEX) (JNPR) Higher; (ATOS) (PTCT) (ISRG) Lower (more...)